Report

Sperm calcineurin inhibition prevents mouse fertility with implications for male contraceptive

See allHide authors and affiliations

Science  01 Oct 2015:
aad0836
DOI: 10.1126/science.aad0836

You are currently viewing the abstract.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution

Abstract

Calcineurin inhibitors, cyclosporine A and FK506, are used as immunosuppressant drugs but their adverse effects on male reproductive function remain unclear. The testis expresses somatic calcineurin and a sperm-specific isoform that contains a catalytic subunit (PPP3CC) and a regulatory subunit (PPP3R2). We demonstrate herein that Ppp3cc and Ppp3r2 knockout male mice are infertile with reduced sperm motility due to an inflexible midpiece. Treatment of mice with cyclosporine A or FK506 phenocopies the sperm motility and morphological defects. These defects appear within 4-5 days of treatment indicating that sperm-specific calcineurin confers midpiece flexibility during epididymal transit. Mouse male fertility recovered a week after discontinuing treatment. Since human spermatozoa contain PPP3CC/PPP3R2 as a functional calcineurin, inhibition of sperm-specific calcineurin may lead to the development of a reversible male contraceptive targeting spermatozoa in the epididymis.

View Full Text